3-Hydroxyoctanoic Acid
CAS No. 14292-27-4
3-Hydroxyoctanoic Acid( —— )
Catalog No. M28858 CAS No. 14292-27-4
3-Hydroxyoctanoic Acid is one of the hydroxy-carboxylic acids (HCAs) that serve as intermediates of energy metabolism. It is an agonist of the orphan receptor GPR109B.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 49 | In Stock |
|
| 25MG | 85 | In Stock |
|
| 50MG | 129 | In Stock |
|
| 100MG | 184 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 479 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Hydroxyoctanoic Acid
-
NoteResearch use only, not for human use.
-
Brief Description3-Hydroxyoctanoic Acid is one of the hydroxy-carboxylic acids (HCAs) that serve as intermediates of energy metabolism. It is an agonist of the orphan receptor GPR109B.
-
Description3-Hydroxyoctanoic Acid is one of the hydroxy-carboxylic acids (HCAs) that serve as intermediates of energy metabolism. It is an agonist of the orphan receptor GPR109B.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorD3 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14292-27-4
-
Formula Weight160.21
-
Molecular FormulaC8H16O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 42.5 mg/mL (265.28 mM)
-
SMILESCCCCCC(CC(O)=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rudmann DG, et al. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864. Toxicol Pathol. 2004 May-Jun;32(3):326-32.
molnova catalog
related products
-
WAY-622024
WAY-622024 is an agonist of the orphan human GPCR GPR109B.
-
ML 145
ML 145 is a selective and potent antagonist of human GPR35, with no significant activity against GPR35 in any of its immediate rodent homologs.
-
Myristyl nicotinate
Myristyl nicotinate is an ester prodrug being developed for delivery of nicotinic acid (NIC) into the skin for prevention of actinic keratosis and its progression to skin cancer.
Cart
sales@molnova.com